Back

Who will benefit from ICD implantation in non-ischemic cardiomyopathies?

26 August 2018 (07:52 - 08:15)
Organised by:
Congress Presentation Part of: Controversial issues in non-ischemic cardiomyopathies Diagnostic Methods ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Daniel B Mark

Duke University Medical Center, Durham (United States of America)

1 More presentation in this session

Presentation thumbnail
Who needs genetic testing in non-ischemic cardiomyopathies?
Doctor A. Cannata (London, GB)
Slides Video

Access the full session

Session thumbnail
Controversial issues in non-ischemic cardiomyopathies

The Event

Event poster

ESC Congress 2018

26 August 2018 07:52 CET
You may be interested in
thumbnail
Congress Presentation
Ten-year follow-up of implantable cardioverter-defibrillator device implantation in non-ischaemic cardiomyopathy - an insight from real world practice in a large district general hospital.
27 August 2021
thumbnail
Congress Presentation
New concepts in sudden death risk stratification in the cardiomyopathies
27 August 2023
thumbnail
Congress Session
Arrhythmias and devices
17 May 2025
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type
18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources